Showing results (391-400 of 408) with videos related to

Sort By:
Pageof 41
American Journal of Ophthalmology|November 5, 2003
Acute endophthalmitis following intravitreal triamcinolone acetonide injectionDarius M Moshfeghi, Peter K Kaiser, Ingrid U Scott, et al.
American Journal of Ophthalmology|August 28, 2018
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX StudyKun Liu, Yanping Song, Gezhi Xu, et al.
Eye (London, England)|November 12, 2022
Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trialsVarun Chaudhary, Gurkaran S Sarohia, Mark R Phillips, et al.
Ophthalmology. Retina|July 5, 2022
Role of Positioning after Full-Thickness Macular Hole Surgery: A Systematic Review and Meta-AnalysisVarun Chaudhary, Gurkaran S Sarohia, Mark R Phillips, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 11, 2012
Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degenerationQuan Dong Nguyen, Peter A Campochiaro, Syed Mahmood Shah, et al.
Retina (Philadelphia, Pa.)|March 7, 2024
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel GuidanceCharles C Wykoff, Robert L Avery, Mark R Barakat, et al.
BMJ Open Ophthalmology|October 19, 2023
Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatmentPeter K Kaiser, Paul M Karpecki, Carl D Regillo, et al.
Ophthalmology|October 23, 2012
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationJeffrey S Heier, David M Brown, Victor Chong, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 29, 2021
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical TrialDavid S Boyer, Victor H Gonzalez, Derek Y Kunimoto, et al.
Ophthalmology Science|April 9, 2024
Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye DiseaseLi Xu, Jessi R Prentice, Raul Velez-Montoya, et al.
Pageof 41